Researchfest 2020 Abstracts Room # Indicates Where To

Total Page:16

File Type:pdf, Size:1020Kb

Researchfest 2020 Abstracts Room # Indicates Where To ResearchFest 2020 Abstracts Room # indicates where to find the video poster on the padlet.com/researchfest2020 sites ROOM TITLE AUTHORS # B1 Implementation of VMAT for of breast cancer with nodal involvement Angela Viotto, Dr Michael Chao, Dr Farshad Foroudi, Leah McDermott, Karen Daly and Ben Starvaggi B2 Evaluation of a safe neutrophil count for cessation of IV antibiotics and Chih-Chiang Hu, Rakhee Subramanian, Andrew Grigg early hospital discharge in stable, afebrile patients recovering after acute myeloid leukaemia (AML) therapy or an autograft B3 Renin Angiotensin System inhibitors modulate the immunoproteasome Vallejo-Ardila DL, Paolini R, Ang CS, Kastrapis G, Fifis T, Walsh K, Christophi C, Perini expression in the tumour and liver tissues of mice with colorectal liver MV metastasis B4 The Prognostic Value of Immune Profiling Colorectal Liver Metastases Vallejo-Ardila DL, Fifis T, De Bastiani M A, Williams D, Walsh K, Tai J, Banting J, Follows a Spatial Distribution Muralidharan V, Christophi C, Perini M V B5 Early FDG-PET-based assessment of response in Anal Cancer using Smith D, Lau E, Lim Joon D, Knight K, Foroudi F, Schneider M, Khoo V manual and semi-automatic methods B6 The incidence of central line-associated blood stream infections in Elena Tarasenko & Emma Cohen allograft and autograft patients. B7 Tumor volume as a predictor of response to anti-EGFR ADC ABT-414 HK Gan, A Seow, E Lau, M Ameratunga, Y Perchonok, D Cao, A Rigopoulos, H-J Lee, E Gomez, D Maag, A Scott B8 Prolonged lymphopenia and infection risk is mitigated by antimicrobial Kate Manos, Masa Lasica, Andrew Grigg, Pietro Di Ciaccio, Jonathan Wong, Usha prophylaxis in patients with indolent non-Hodgkin Lymphoma (iNHL) Chandra Sekaran, Joel Wight, Zhong Goh, Hayden Jina, Llewyn Butler, Costas treated with bendamustine +/- anti-CD20 antibody: the Australasian Yannakou, Nada Hamad, Gareth Gregory, Shane Gangatharan, Tara Cochrane, Lymphoma Alliance experience Kristen Piper, Leonid Churilov, Eliza Hawkes B9 Correlation between PET biomarkers and outcomes in patients with M. Huynh, R. Boktor, K. Pathmaraj, Sylvia Gong, A.Lim, S. Berlangieri, E.Lau, A. Scott malignant lung masses treated with SABR. A preliminary report. B10 Response evaluation and survival prediction following PD-1 Ayati N.; Lee S.T.; Zakavi S.R.; Chen M; Lau W.F.E.; Parakh S.; Pathmaraj K.; Scott immunotherapy in non-small-cell lung cancer (NSCLC) patients: A.M. comparison of assessment methods. B11 Taxane-induced neuropathy: how serious is this problem for patients Robert Nicolae; Belinda Yeo; Jim Siderov; and Vannesa Wong. with early breast cancer? B12 Implementation of an automated production of F-18 fluoroestradiol at Uwe Ackermann, Ingrid Burvenich, Sze Ting Lee, Farshad Faroudi, Kenneth Young, Austin Health Graeme O'Keefe, Andrew Scott B13 Fleuorination of oncrasin analogues for imaging of kras mutant tumors Uwe Ackermann, Alexander McDonald, Yit Wooi Goh, Jonathan White, Andrew Scott B14 This abstract is not included at the request of the author Allison Barraclough, James England, Joel Wight, Greg Hapgood, Jason Conn, Michael Gilbertson, Briony Shaw, Mark Bishton, Malik Saeed, Geoff Chong, Shin Hnin Wai, Matthew Ku, Hui-Peng Lee, Kathryn Fleming, Constantine Tam, Genevieve Douglas, Chan Cheah, Zi Yun Ng, Tukten Rolfe, Anthony K Mills, Nada Hamad, Helen Cashman, Mary Gleeson, Manjunath Narayana, Diego Villa, Eliza Hawkes B15 This abstract is not included at the request of the author Allison Barraclough, Edward Yoo, Chan Y. Cheah, Dipti Talaulikar, Bianca Nguyen, Michelle Turner, Fatima Tahir, Jing Huang, Colm Keane, Mitchel Lincoln, Tara Cochrane, Anna M. Johnston, Michael Dickinson, Stephen Opat, Zoe K. McQuilten, Erica M. Wood, Gayathri St George, Cameron Wellard, Eliza A. Hawkes B16 This abstract is not included at the request of the author Allison Barraclough, Geoff Chong, Michael Gilbertson, Andrew Grigg, Leonid Churilov, Tineke Fancourt, David Ritchie, Rachel Koldej, Rishu Agarwal, Kate Manos, Charmaine Smith, Kristen Houdyk, Joanne Hawking, Eliza A Hawkes B17 This abstract is not included at the request of the author Anne Huber, Christine Dijkstra, Mattthias Ernst, Moritz Eissmann B18 This abstract is not included at the request of the author Roelofs, C. Chakrabarti, A. Redvers, R. Anderson, A. B19 This abstract is not included at the request of the author Cox DRA, Low N, Goh SK, Christophi C, Testro A, Dobrovic A, Muralidharan V. B20 This abstract is not included at the request of the author Koshy AN, Ko J, Farouque O, Cooray SD, Han HC, Cailes B, Gow P, Weinberg L, Testro A, Lim HS, Teh AW B21 This abstract is not included at the request of the author Lap Hing Chi, Allan D. Burrows and Robin L. Anderson B22 This abstract is not included at the request of the author Riddiough GE, Walsh K, Fifis T, Tran BM, Muralidharan V, Vincan E, Christophi C, Perini M B23 This abstract is not included at the request of the author Riddiough GE, Tran BM, Fifis T, Walsh K, Muralidharan V, Christophi C, Vincan E, Perini M G1 The impact of antibiotic allergy testing in transplant patients A Ying, KYL Chua, M Rose, S Vogrin, JA Trubiano G2 The CANBACK trial: a randomised, double-blind, placebo-controlled, Bronwyn Bebee, David McD Taylor, Elyssia Bourke, Lian Foster, Kimberley Pollack, clinical trial assessing the usefulness of CANnabidiol for BACK pain in the Anselm Wong emergency department. G3 The effect of body position on maternal cardiovascular function during Danielle L. Wilson, Anna Ishkova, Mark E. Howard, Susan P. Walker, Maree Barnes, sleep and wakefulness in late pregnancy Christian L. Nicholas, Amy S. Jordan G4 Progressive Fibrosing Interstitial Lung Disease: An Epidemiological Duncan J Sweeney, Yet H Khor, Nicole SL Goh Description and the Unmet Care Needs G5 Audit of body temperature (BT) over the first four hours after the start Baldwin I, Thummaporn, N, Bellomo R of continuous renal replacement therapy (CRRT) in intensive care unit (ICU) patients. G6 Treatment functional time (hrs) before clotting using oXiris Ian Baldwin, Naorungroj, Thummaporn, Glenn Eastwood, Rinaldo Bellomo membranes during Intensive Care Unit (ICU) continuous renal replacement therapy (CRRT) in patients with acute liver failure (ALF) and with no anticoagulation. G7 A pilot study to compare the effectiveness of different renal Caleb Fisher, Ian Baldwin, Nigel Fealy, Rinaldo Bellomo, Stephen Warrillow replacement modalities on ammonia clearance in liver disease G8 A low-cost 3D printed tool for radial endobronchial ultrasound Ridgers A, Li J, Coles-Black J, Jiang M, Chen G, Chuen J, McDonald C, Steinfort DP, simulation training Irving LB, Wallbridge P, Jennings BR, Nguyen P, Leong TL G9 Clinicians' Engagement in Infection Prevention and Control and Jennie Sangojoyo, Dr. Emma Cohen, Dr. Ana Hutchinson and Dr. Stéphane Antimicrobial Stewardship in Haematology Settings. Bouchoucha G10 Eye blink drowsiness assessed pre- and post-driving detects severe Jennifer M Cori, Vanessa E Wilkinson, Shamsi Shekari Soleimanloo, Justine drowsy driving Westlake, Bronwyn Stevens, Shantha MW Rajaratnam and Mark E Howard G11 Conducting a non-contact sleep study in the era of COVID-19 J. Tolson, E. Papapathwala, J.Kristek, CJ Worsnop G12 SSRIs do not reduce psychological distress, but increase adverse events Liem Tran, Kelsey Sharrad, Zoe Kopsaftis, Helen M Stallman, Andrew Tai, Nicola among adults with asthma: a systematic review and meta-analysis Spurrier, Adrian Esterman, Kristin Carson-Chahhoud G13 Identifying trends in hospital admissions during the COVID-19 pandemic Chan RK, Goel V, Smibert OC, Holmes NE, Marhoon N, Bach CT, Trubiano JA, Jones in a low-prevalence country - a single centre retrospective study NR G14 Lung nodule evaluation: An audit of adherence with Fleischner Laura Tu, Raymond Wong, Christine McDonald, Fergal O'Donoghue, Tracy Leong Guidelines G15 The MONitoring Knockbacks in EmergencY (MONKEY) audit: What are Lee Yung WONG & Soham SARKAR the disposition outcomes for Emergency patients initially declined admission? G16 The predictive value of small short-term creatinine increases detected Toh LY, Wang AR, Bitker L, Eastwood GM, Bellomo R by arterial blood gases in ICU G17 Oximetry can detect severe obstructive sleep apnoea in acute Torning A, Hultling C, Berlowitz DJ, Hernvald G, Jackobsson C, New P, Graco M tetraplegia with moderate accuracy G18 Prevalence of sleep-disordered breathing in people with tetraplegia - a Graco M, McDonald L, Green SE, Jackson ML, Berlowitz DJ systematic review and meta-analysis G19 Spinal cord injury rehabilitation centres can (and do) independently Graco M, Gobets D, O'Connell C, Baumberger M, Mueller G, Daniels B, Knowles B, diagnose and treat non-complicated sleep-disordered breathing Lustenberger H, Berlowitz DJ G20 A randomised controlled trial of regular lung volume recruitment vs Sheers N, Howard ME, Rautela L, Chao C, Berlowitz DJ active control in people with neuromuscular disease G21 How do filters added for COVID-19 affect non-invasive ventilator Rodney Hone, Christian Bandiera, Linda Rautela, Mark Howard, Christopher performance? Worsnop, Tom Churchward, Julie Tolson G22 The impact of the 2019 ATS/ERS criteria for back extrapolation volume Sharifi V, Ruehland W, Lanteri C, Brazzale D on spirometry results. G23 Relationship between smoking status and post-operative complication Vishnu Jeganathan, Matthew Bricknell, Anna Ridgers, Raymond Wong, Danny after lung cancer resection surgery Brazzale, Warren Ruehland, Muhammad Aziz Rahman, Tracy Leong, Simon Knight,
Recommended publications
  • Cortical Connections 2015
    Cortical Connections 2015 19th and 20th of March, 2015 Queensland Brain Institute Brisbane, Australia Program, Speaker Biographies, and Abstracts Programme Day 1 Thursday March 19 Programme Day 1 Thursday March 19 8:15AM Registration open Session 2: Genetics of cortical wiring disorders 8:45AM Welcome by Prof. Linda Richards Queensland Brain Institute 12:00– Prof. Elliott Sherr 1:00PM University of California, San Francisco Cerebral connectivity: from genes to cognition Session 1: Development of cortical wiring 1:00– Lunch at QBI 9:00– Prof. Roberto Lent 1:30PM 10:00AM Federal University of Rio de Janeiro 1:30– Distance plasticity - on connectomes Prof. Jozef Gécz 2:00PM University of Adelaide and dysconnectomes Protocadherin 19 and female limited 10:00– Dr Richard Leventer epilepsy and intellectual disability Session chairs 10:30AM Dr Jens Bunt Murdoch Childrens Research Institute, Melbourne 2:00– Agenesis of the corpus callosum and the Prof. Kathryn North and 2:30PM Director, Murdoch Childrens Research Institute, company it keeps Dr Peter Kozulin Session chairs Melbourne 10:30– Dr Ilan Gobius Learning disabilities in childhood – lessons from Prof. Stephen Williams and 11:00 AM Queensland Brain Institute Ms Laura Fenlon Active dendritic integration underlies circuit- 2:30– based neocortical computations Prof. Ingrid Scheffer 3:00PM The University of Melbourne, Florey Neurosciences 11:00 – Institute, Murdoch Childrens Research Institute, 11:30 AM Morning tea on the QBI terrace Melbourne Genetics of the epilepsies—framing cortical 11:30 AM– Prof. Linda Richards connections 12:00PM Queensland Brain Institute Development of the corpus callosum 3:00– 3:30PM Afternoon tea 3:30– Prof.
    [Show full text]
  • Paediatric Epilepsy Research Report 2019
    Paediatric Epilepsy 2019 Research Report Inside Who we are The organisations and experts behind our research programme What we do Our strategy, projects and impact youngepilepsy.org.uk Contents Introduction 1 Who we are 2 Research Partners 2 Research Funding 4 Research Team 5 What we do 10 Programme Strategy 10 The MEG Project 12 New Research Projects 14 Research Project Update 21 Completed Projects 32 Awarded PhDs 36 Paediatric Epilepsy Masterclass 2018 37 Paediatric Epilepsy Research Retreat 2019 38 Research Publications 40 Unit Roles 47 Unit Roles in Education 49 Professional Recognition and Awards 50 Paediatric Epilepsy Research Report 2019 Introduction I am delighted to present our annual research report for the period July 2018 to June 2019 for the paediatric epilepsy research unit across Young Epilepsy, UCL GOS - Institute of Child Health and Great Ormond Street Hospital for Children. We have initiated 13 new research projects, adding to 20 active projects spanning the clinical, educational and social elements of paediatric epilepsy. We have published 110 peer-reviewed items of primary research and a further 54 chapters in books, reviews and commentaries of expert opinion. During this period, Young Epilepsy Chief Executive Carol Long caught the research bug and moved on to begin her PhD at Durham University. We welcomed our new Chief Executive, Mark Devlin at our Paediatric Epilepsy Research Retreat in January 2019. As an organisation, we are launching a new strategy This report features a spotlight on a truly which sets our research programme as one of innovative project which will change the UK’s the four key offers at Young Epilepsy, and we diagnostic and surgical evaluation imaging suite look forward to sharing our research more widely for childhood epilepsy.
    [Show full text]
  • 2016 Annual Review a Summary of Our Year
    2016 Annual Review A summary of our year Royal Society Te Apārangi 0 Contents Introduction from the President ............................................................................................................... 2 Explore ........................................................................................................................................................... 3 Increased funding allowed Marsden Fund to support more early-career researchers ............................. 3 Supporting established researchers to explore their area of expertise .................................................... 3 Supporting early career researchers to become leaders .......................................................................... 4 Supporting emerging researchers to develop their careers ...................................................................... 4 ORCID Consortium will help close the loop on New Zealand’s research system ....................................... 5 Powering Potential on climate change ...................................................................................................... 6 NZIFST/CREST Student Product Development Challenge .......................................................................... 6 Teachers in Industry .................................................................................................................................. 6 Science Teaching Leadership Programme ................................................................................................
    [Show full text]
  • Melbourne Neuroscience Institute 2017 Annual Report
    Melbourne Neuroscience Institute 2017 Annual Report A © The Melbourne Neuroscience Institute Enquiries for reprinting information contained in this publication should be made through: [email protected] Every attempt has been made to ensure that the information in this publication was correct at the time of printing. Editor: Amy Bugeja Designer: External Relations 23201 For further information visit: www.neuroscience.unimelb.edu.au Contents Executive Summaries 02 Research 04 Engagement 32 Partnerships 45 Funding Initiatives 50 Governance 54 1 CHAPTER 1 Executive Summaries Message from the Director It is with great pleasure that we table the 2017 annual report for the Melbourne Neuroscience Institute (MNI). The MNI has now been extant for 8 years and during that time it has unwaveringly served to promote the Neurosciences and related disciplines at the University of Melbourne. This report serves to demonstrate both the current strength of Neuroscience research on campus and the role that MNI has played in fostering many of these activities. The spectrum of Neuroscience research conducted at this University is impressive and what is presented in this report is an important but, by necessity, a small proportion of the exciting work that is being conducted. What is very apparent is that much of the work relies on strong collaborative interactions and often those collaborative interactions span several faculties. I am particularly pleased to see this, reflecting that the promotion of Our international interface continues to strengthen. This is most interdisciplinarity that has been one of the key goals of MNI, apparent through our strong links with the Salpetriere in Paris and an outcome that we have been able to facilitate via our with the Hotchkiss Brain Institute in Calgary.
    [Show full text]
  • Classification of the Epilepsies and to Solicit Tion Framework Proves Incompatible with New Findings, We Comments and Criticism from Readers
    SPECIAL REPORT Classification of the epilepsies: New concepts for discussion and debate—Special report of the ILAE Classification Task Force of the Commission for Classification and Terminology1 *†‡Ingrid E. Scheffer, §Jacqueline French, ¶#Edouard Hirsch, **Satish Jain, ††Gary W. Mathern, ‡‡Solomon L Moshe, §§Emilio Perucca, ¶¶Torbjorn Tomson, ##Samuel Wiebe, ***Yue-Hua Zhang, and †††‡‡‡Sameer M. Zuberi Epilepsia Open, 1(1):37–44, 2016 doi: 10.1002/epi4.5 SUMMARY The ILAE Task Force on Classification presents a road map for the development of an updated, relevant classification of the epilepsies. Our objective is to explain the pro- cess to date and the plan moving forward as well as to invite further discussion about the newly proposed terms and concepts. Here, we present our response to feedback about the 2010 Organization of the Epilepsies and clarify the reintroduction of the word “classification” to map out a framework for epilepsy diagnosis. We introduce some new concepts and suggest four diagnostic levels: seizure type, epilepsy category, epilepsy syndrome, and epilepsy with (specific) etiology to denote specific levels of diagnosis. We expand the etiological categories to six, focusing on those with treat- ment implications. Finally, we discuss the changes in terminology originally suggested Prof Ingrid Scheffer and modifications in response to comments from the epilepsy community. We wel- chairs the ILAE Task come feedback and discussion from the global epilepsy community, particularly for the Force on the new suggested terms, so that we can cement a classification that both reflects current Classification of the thinking and scientific understanding and provides a dynamic, evolving framework. Epilepsies.
    [Show full text]
  • Newsletter ISSUE NUMBER 4 2005 PILEPSY ESEARCH E R Elcome to the 2005 Edition of the Experience from Their Countries, and We C ENTRE Wepilepsy Genetics Newsletter
    EPILEPSY GENETICS Newsletter ISSUE NUMBER 4 2005 PILEPSY ESEARCH E R elcome to the 2005 edition of the experience from their countries, and we C ENTRE WEpilepsy Genetics Newsletter. We all benefit enormously from the Austin Health like to keep you informed of all our excit- opportunity to exchange ideas. Heidelberg Repatriation Hospital, ing developments from our last year of Sadly, during 2004 we said farewell to Banksia Street,West Heidelberg, hard work here at the Epilepsy Research Centre at Austin Health,Melbourne and the several members of our team. Dr Lata Victoria 3081 University of Melbourne. We also take this Vadlamudi moved to become an academic Tel: (03) 9496 2737 opportunity to thank all of our five and a neurologist in Canberra where she will Fax: (03) 9496 2291 half thousand research participants and complete her PhD thesis, and Dr Nigel Tan Email: [email protected] supporters for their time and energy in returned to Singapore after spending 18 Website: www.epilepsyresearch.org.au helping our research to continue. Without months with us. We hope to keep working their kind assistance and enthusiastic closely with both Dr Vadlamudi and Dr Tan attitude to the research, our continuing in the coming years. Two research success and progress in the field would assistants, Sarah McInnes and Deborah not be possible. Keay (Glencross), also left the team during 2004. The research team, headed by Professor Sam Berkovic and Associate Professor Our work in the area of the genetics Ingrid Scheffer, is now in its 16th year and of epilepsy continues to progress well we continue striving to unravel the with a number of important scientific Professor Samuel Berkovic inheritance of seizures in both families and publications throughout the year.
    [Show full text]
  • Life As a Clinician-Scientist
    2021 VICTORIAN SYMPOSIUM Life as a Clinician-Scientist Saturday 31 July Monash University About the Academy The Australian Academy of Health and Medical Sciences is the impartial, authoritative, cross-sector voice of health and medical science in Australia. We are an independent, interdisciplinary body of 425 Fellows – elected by their peers for their distinguished achievements and exceptional contributions to health and medical science in Australia. Collectively, they are a representative and independent voice, through which we engage with the community, industry and governments. The Academy is uniquely positioned to convene cross-sector stakeholders from across Australia to address the most pressing health challenges facing society. We focus on the development of future generations of health and medical researchers, on providing independent advice to government and others on issues relating to evidence based medical practice and medical researchers, and on providing a forum for discussion on progress in medical research with an emphasis on translation of research into practice. The Academy is registered with the Australian Charities and Not-for-profits Commission (ACNC) and in endorsed as a deductible gift recipient. www.aahms.org @MedSciAcademy @AAHMS_Health Welcome to Life as a Clinician-Scientist Today we welcome you to showcase Life as a Clinician-Scientist. Our speakers will share their unique journeys that have led to a rich and rewarding career, filled with challenge and discovery. Why consider life as a clinician-scientist? Clinician-scientists have a unique and irreplaceable set of skills, enabling them to marry key clinical questions with insights into human biology. Medicine integrated with science allows you to take clinical observations and curiosities from the bedside, to answer deeper scientific questions, and translate these to have far reaching impact on improving patients’ lives.
    [Show full text]
  • Variable Clinical and Molecular Expressivity of PCDH19 Variants and Girls Clustering Epilepsy
    Variable Clinical and Molecular Expressivity of PCDH19 Variants and Girls Clustering Epilepsy A disorder of cellular “mosaics” Thesis submitted for the degree of Doctor of Philosophy by Kristy Louise Kolc BSc-Psychology (Hons) April 2020 School of Population Health Faculty of Health Sciences The University of Adelaide, Australia University of Adelaide Adelaide Medical School, Faculty of HealthAustralia and Medical Sciences Children see magic because they look for it - Christopher Moore Science is nothing but perception. - Plato Title Variable Clinical and Molecular Expressivity of PCDH19 Variants and Girls Clustering Epilepsy: A disorder of cellular “mosaics” Author Kristy Kolc Institute Adelaide Medical School Academic advisors Professor Jozef Gecz, Adelaide Medical School A/Prof Rachel Roberts, School of Psychology Dr Duyen Pham, Adelaide Medical School Dr Raman Kumar, Adelaide Medical School Adelaide Medical School University of Adelaide Adelaide Health and Medical Sciences Building ADELAIDE SA 5000 E-mail: [email protected] webpage: https://health.adelaide.edu.au/medicine/ TABLE OF CONTENTS TABLE OF CONTENTS TABLE OF CONTENTS .............................................................................................................. i LIST OF TABLES ....................................................................................................................... v LIST OF FIGURES .................................................................................................................... vi LIST OF ABBREVIATIONS
    [Show full text]
  • Paediatric Epilepsy Research Report 2020
    Paediatric Epilepsy 2020 Research Report Inside Who we are The organisations and experts behind our research What we do Our strategy, projects and impact youngepilepsy.org.uk Contents Introduction 1 Who We Are 2 Research Partners 2 What We Do 4 Research Strategy 4 Research Impact 7 Past Impact 8 Current Impact 10 What’s Next 12 Research Projects 13 New Projects 14 Ongoing Projects 22 Completed Projects 37 Research Funding 42 Further Activities 43 E-CURe Network Launch 43 Young Epilepsy Research Retreat 2020 44 Collaborative Awards 45 Research Team 46 Congratulations 51 Research Publications 52 Glossary 57 Paediatric Epilepsy Research Report 2020 Introduction I am delighted to present our annual research report for the period July 2019 to June 2020 for the paediatric epilepsy research partnership across Young Epilepsy, UCL GOS - Institute of Child Health and Great Ormond Street Hospital for Children. During this period, we have initiated 15 new research projects, adding to 30 active projects spanning the clinical, educational and social elements of paediatric epilepsy. We have published 62 peer-reviewed items of primary research, 28 reviews and a further 5 chapters in books. We continue to share expertise with research and clinical colleagues and in January 2020 held our 10th International Paediatric Epilepsy Research Retreat for researchers and collaborators across the unit. This meeting was a wonderful celebration of the work of the unit over the past decade. We enjoyed record attendance as well as welcoming two eminent Research Moderators; Professor Alexis Arzimanoglou of University Hospitals of Lyon, and Professor Mathias Koepp of even greater still, the changes to all lives and pursuits UCL Queen Square Institute of Neurology.
    [Show full text]
  • “La Genomica in Sanità Pubblica: Attualità E Futuro”
    Curricula RELATORI M. 0701-08 Rev. 00 del 07/04/2014 Silvia De Rubeis E-mail [email protected] Date of birth 03/05/1982 Work address Dept. Psychiatry, Icahn School of Medicine at Mount Sinai Home address 68 E 97th street apt 24, New York, 10029 NY Phone +1-212-241-0241 Nationality italian Research experience 03/2013-present Seaver postdoctoral fellow Dept. Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA Dr. Joseph D. Buxbaum 01/2010-12/2012 Postdoctoral fellow Center for Human Genetics, Katholieke Universiteit Leuven, Belgium Dr. Claudia Bagni 03-04/2010 EMBO short-term postdoctoral fellow Center for Neural Science, New York University, New York, USA Dr. Eric Klann Education 2006-2009 PhD in Cellular and Molecular Biology University of Rome ‘Tor Vergata’, Rome, Italy Dr. Claudia Bagni 2004-2006 Master bachelor in Cellular and Molecular Biology University of Rome ‘Tor Vergata’, Rome, Italy Dr. Claudia Bagni 2001-2004 Bachelor in Molecular and Cellular Biology University of Rome ‘Tor Vergata’, Rome, Italy Dr. Patrizia M. Baldini Publications 1. Ionita-Laza I, Capanu M, De Rubeis S, McCallum J, Buxbaum JD. Identification of rare causal variants in sequence-based studies: methods and applications to gene VPS13B, involved in Cohen syndrome and autism. PLoS Genetics, 10(12):e1004729 2. De Rubeis S, He X, Goldberg AP, Poultney CP, et al. Synaptic, chromatin and transcriptional genes disrupted in autism. Nature, 515(7526), 209-15 3. Braat S, D’Hulst C, Heulens I, De Rubeis S, Mientjes E, Nelson DL, Willemsen R, Bagni C, Van Dam D, De Deyn PP, Kooy RF.
    [Show full text]
  • Download the Trustees' Report and Financial Statements 2018-2019
    Science is Global Trustees’ report and financial statements for the year ended 31 March 2019 The Royal Society’s fundamental purpose, reflected in its founding Charters of the 1660s, is to recognise, promote, and support excellence in science and to encourage the development and use of science for the benefit of humanity. The Society is a self-governing Fellowship of distinguished scientists drawn from all areas of science, technology, engineering, mathematics and medicine. The Society has played a part in some of the most fundamental, significant, and life-changing discoveries in scientific history and Royal Society scientists – our Fellows and those people we fund – continue to make outstanding contributions to science and help to shape the world we live in. Discover more online at: royalsociety.org BELGIUM AUSTRIA 3 1 NETHERLANDS GERMANY 5 12 CZECH REPUBLIC SWITZERLAND 3 2 CANADA POLAND 8 1 Charity Case study: Africa As a registered charity, the Royal Society Professor Cheikh Bécaye Gaye FRANCE undertakes a range of activities that from Cheikh Anta Diop University 25 provide public benefit either directly or in Senegal, Professor Daniel Olago from the University of indirectly. These include providing financial SPAIN UNITED STATES Nairobi in Kenya, Dr Michael OF AMERICA 18 support for scientists at various stages Owor from Makerere University of their careers, funding programmes 33 in Uganda and Professor Richard that advance understanding of our world, Taylor from University College organising scientific conferences to foster London are working on ways to discussion and collaboration, and publishing sustain low-cost, urban water supply and sanitation systems scientific journals.
    [Show full text]
  • Perception, Imagination and Change
    Epilepsy Perception, imagination and change Medical History Museum, University of Melbourne Epilepsy is one of the most common neurological conditions, affecting one in 26 people during their lifetime. Despite its prevalence, epilepsy has long been misunderstood, immersed in superstition, fear and prejudice. In the 19th century neurologists began to understand the causes Epilepsy of the disorder, although misleading terms such as ‘the dreamy state’, ‘psychic seizures’ Perception, imagination and change and ‘double consciousness’ prevailed. Even today, fear and misinformation affect the daily lives of many people with this condition. Epilepsy: Perception, imagination and change explores different cultural and historical perspectives on epilepsy, and includes accounts from scientists and physicians whose discoveries are improving the quality of lives of people with epilepsy. Both the book and the exhibition held at the University of Melbourne’s Medical Edited by History Museum in 2014 embrace research Jim Chambliss, Mark Cook and Jacqueline Healy undertaken by Dr Jim Chambliss in collaboration with artists who have epilepsy. Many of their works are reproduced here, accompanied by their own descriptions of their art and its place in their lives. This book increases our understanding and awareness of epilepsy. The history affects our perceptions of the condition, the artwork shows the power of the artists’ imaginations, and the innovative work of leading researchers points to the changes ahead. Medical History Museum, University of Melbourne Published 2014 by the Medical History Museum, Faculty of Contents Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, 3010, Australia, http://museum.medicine.unimelb.edu.au. © Copyright the authors, the artists or their estates, and the University of Melbourne, 2014.
    [Show full text]